Polydopamine-Infused Calcium Phosphate ECM Bone Graft Scaffold
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone graft substitutes, such as Infuse™ Bone Graft and Vitoss, face limitations including bio-disparate design, supraphysiologic burst release of growth factors, and brittleness, which can lead to complications and reduced efficacy in bone formation.
Innovation Solution
A novel bone graft material comprising a porous, homogeneously dispersed solid mixture of calcium phosphate and extracellular matrix (ECM) infused with polydopamine, created from a one-pot liquid ECM hydrogel solution at room temperature, allowing for controlled growth factor release and flexibility, and enabling the incorporation of various additives like antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If BMP-2 is used in high concentration for bone formation, then bone formation efficacy is improved, but adverse events and life-threatening complications increase
Solution Approach 1:
The patent changes the concentration parameter of BMP-2 from supraphysiologic (high) to physiologic (low) levels, and changes the release pattern from burst to sustained controlled release. This resolves the contradiction by maintaining effective bone formation through sustained stimulation while avoiding the harmful effects associated with high-concentration bolus delivery.
Solution Approach 2:
The patent implements periodic, sustained release of BMP-2 rather than a single bolus dose. The controlled release system delivers BMP-2 continuously at physiologic concentrations over time, mimicking natural bone formation processes and avoiding the harmful peak concentrations that cause adverse events.
2Reliability
If calcium phosphate bone graft substitute is used, then bone formation is promoted, but brittleness and susceptibility to breakage increase
Solution Approach 1:
The patent creates a composite material system combining calcium phosphate particles with a collagen-type gel matrix. The collagen matrix provides flexibility and toughness to prevent breakage during implantation, while the calcium phosphate particles maintain their bone-forming properties. This composite structure resolves the contradiction between bone formation efficacy and mechanical strength.
3Reliability
If autologous bone is used for grafting, then bone formation efficacy is improved, but surgical time and patient morbidity increase
Solution Approach 1:
The patent uses an allogeneic or synthetic bone graft substitute (collagen gel with calcium phosphate and BMP-2) that can be prepared and stored independently of the patient. This eliminates the need for time-consuming autologous bone harvesting procedures while providing reliable bone formation, thus resolving the contradiction between efficacy and surgical time.
4Reliability
If collagen sponge soaked in BMP-2 solution is used, then bone formation is achieved, but the design is bio-disparate and growth factor release is uncontrolled
Solution Approach 1:
The patent merges the growth factor (BMP-2) directly into the collagen matrix structure through covalent binding or encapsulation, creating an integrated system where the collagen and BMP-2 work together as a unified bioactive scaffold. This eliminates the bio-disparate design of separate sponge and solution components and enables controlled release through the integrated structure.
Solution Approach 2:
The patent uses the collagen matrix as an intermediary carrier that mediates controlled release of BMP-2. The collagen structure provides a physical and chemical framework that regulates BMP-2 release kinetics, transforming uncontrolled burst release into sustained physiologic-level delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This biomimetic scaffold provides effective and sustained bone formation with reduced risk of infection and complications, offering a flexible and versatile solution for bone grafting procedures by mimicking the composition and structure of natural bone.
Implementation Method 1
contacting the material with a solution of dopamine forming an activated material infused with polydopamine
Implementation Method 2
created from a one-pot liquid ECM hydrogel solution at room temperature
Implementation Method 3
lyophilizing the mixture forming a material
Data Source
AI summary
The present invention pertains to novel bone graft substitute materials. These materials are porous, homogenously dispersed solid mixtures of calcium phosphate and pro-regenerative extracellular matrix (ECM)—and potentially any pharmaceutical agent and/or mineral—that have been infused with polydopamine. In some embodiments the bone graft materials have osteoinductive factors incorporated within them.